Skip to content

Fatigue and Inspiratory Muscles Training in Patients With Multiple Sclerosis

Fatigue and Inspiratory Muscles Training Against Resistance in Patients With Multiple Sclerosis With Severe Disabilities

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02726672
Acronym
AIRSEP
Enrollment
46
Registered
2016-04-04
Start date
2016-02-29
Completion date
2018-11-30
Last updated
2018-11-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Keywords

inspiratory muscles, multiple sclerosis, rehabilitation

Brief summary

The purpose of this study is to assess the effect of a training of the inspiratory muscles against resistance at home during 10 weeks in multiple sclerosis patients with a severe disability.

Detailed description

Patients will be informed about the study procedures during a follow-up consultation or an hospitalization in a Physical and Rehabilitation Medicine Unit. If they give their informed consent to participate in the study, an investigator will randomize them into one of the 2 arms of the study. This study consists of 3 visits. The first visit (inclusion) is planned at day 0, the second visit 10 weeks later and the third 3 months after day 0. A patient who is randomized in the experimental arm will have to follow 10 weeks of rehabilitation of the inspiratory muscles at home between first and second visit. During this period, investigators will call these patients once a week to assess the compliance with the rehabilitation. The patients who have been randomized in the control group will not follow this rehabilitation program.

Interventions

DEVICErespiratory rehabilitation using Powerbreathe

10 minutes 2 times a day : 30 inspirations per session during 10 weeks

Sponsors

Lille Catholic University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Patient with remitting or progressive multiple sclerosis defined by McDonald criteria revised in 2005, with an EDSS between 6 and 7,5 * Aged between 18 and 65 years * Patients able to maintain the Powerbreathe * Not to have had a flare-up since at least 6 weeks * Patients at least 4 weeks since a corticoid bolus * Patients at least 6 weeks since a botulinum toxin injection * Patients at least 4 weeks since a pulmonary infection * Questionnaire EMIF-SEP \>= 55 * Patients given their informed consent * Patients who benefit or are affiliated to a social security regimen

Exclusion criteria

* Patients with neurologic antecedents other that multiple sclerosis * Patients with respiratory disorders other than those induced by multiple sclerosis * Patients with orthopedic, cardiac, and rheumatologic invalidating antecedents * Patients with comprehension or cognitive disorders impeding the realization of rehabilitation * Pregnant women * Patients under legal guardianship, or safeguard of justice * Patients participating or planning participate within the 3 months of the study to another clinical research project

Design outcomes

Primary

MeasureTime frameDescription
Fatigue graded according to EMIF-SEP questionnaire3 monthsEMIF-SEP questionnaire (French valid version of the Fatigue Impact Scale, self-administered questionnaire to measure fatigue in multiple sclerosis patients)

Secondary

MeasureTime frameDescription
Sleep disorders graded according to the Epworth Sleepiness Scale3 months
Quality of life graded according to the SEP-59 questionnaire3 monthsSEP-59 questionnaire (french validated self-administered questionnaire to assess quality of life in multiple sclerosis patients)
Maximal inspiratory pressure graded according to the Black and Hyatt method3 monthsrespiratory manometer according to Black and Hyatt method
Maximal expiratory pressure graded according to Black and Hyatt method3 monthsrespiratory manometer according to Black and Hyatt method
Forced vital capacity (FVC) graded with a portable spirometer3 months
Tidal volume graded with a portable spirometer3 months
Forced expiratory volume in one second (FEV1) graded with a portable spirometer3 months
FEV1/ FVC ratio graded with a portable spirometer3 months
Energy consumption during repeated effort3 monthsMetamax 3B
Depression graded according to the French version of the Beck Depression Inventory Fast-Screen3 monthsFrench version of the Beck Depression Inventory Fast-Screen, validated scale in multiple sclerosis
Swallowing problems graded according to the DYMUS score3 months
Level of disability graded by the EDSS (Expanded Disability Status Scale)3 monthsThese functional parameters will enable the assessment of the level of disability by a clinical examination
Collection of the drug treatments received evaluated by a questionnaire3 months

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026